A Study on the Clinical and Hormonal Profile of Patients with Hirsutism

    April 2012 in “ Our Dermatology Online ”
    Neerja Puri
    Image of study
    TLDR The conclusion is that PCOS is a common cause of hirsutism in young obese women, and early treatment is important to reduce the risk of metabolic syndrome.
    The study investigated the clinical and hormonal characteristics of 50 female patients with hirsutism, finding that the mean age of onset was 22.4 years and the average severity score was 11.8. Results showed that idiopathic hirsutism was present in 50% of the cases, polycystic ovarian disease (PCOD) in 40%, hypothyroidism in 8%, and congenital adrenal hyperplasia in 2%. Associated conditions included acne (38%), menstrual irregularities (22%), and obesity (20%). Ultrasound results were normal in 60% of patients, but 40% had indications of PCOD. The study concluded that PCOS is a leading cause of hirsutism, especially in young obese women, and emphasized the importance of early intervention to mitigate the risk of metabolic syndrome. It suggested that more extensive studies are needed to validate these findings.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 24 results

      community DHT levels after 4 weeks of Fina and 8 weeks of Fina + 4 weeks of Duta

      in Update  36 upvotes 5 years ago
      The user reported early stage diffuse hair thinning and increased DHT levels after 4 weeks on Finasteride and 8 weeks on Finasteride plus 4 weeks on Dutasteride, despite the medications being authentic and stored properly. They are considering increasing their Dutasteride dosage due to the lack of side effects and are unsure if the treatment is helping their hair.

      community AA and Hirsutism but T levels are normal

      in Female  8 upvotes 3 years ago
      27-year-old female experiences aggressive hair thinning and hirsutism despite normal testosterone levels. Spironolactone and 2% minoxidil were ineffective; high DHEA sulfate levels may be the cause.

      community No, Finasteride as a treatment for MPB was not an "accident"

      in Research/Science  105 upvotes 3 years ago
      Finasteride was intentionally developed to treat BPH and later approved for male pattern baldness (MPB) due to its 5AR inhibition effects. The delay in MPB approval was due to concerns about off-label use for female hirsutism and the prioritization of treating a more debilitating condition.

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  117 upvotes 2 months ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

      community Does low HGH leading to hairloss?

      in Research/Science  13 upvotes 9 months ago
      The user experiencing diffuse hair loss is using various treatments including RU58841, finasteride, minoxidil with tretinoin, anti-hair loss shampoo, and microneedling, and is considering adding peptides TB500, BPC157, and GHK-Cu. They have low growth hormone levels and are questioning its impact on hair loss, while another user suggests androgenic alopecia and androgens are likely the main cause of hair loss.

    Similar Research

    5 / 1000+ results